- Home
- CHRS vs TRX Comparison
CHRS vs TRX Comparison
Compare CHRS & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- TRX
- Stock Information
- Founded
- CHRS 2010
- TRX 1990
- Country
- CHRS United States
- TRX Canada
- Employees
- CHRS N/A
- TRX N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- TRX
- Sector
- CHRS Health Care
- TRX
- Exchange
- CHRS Nasdaq
- TRX Nasdaq
- Market Cap
- CHRS 194.1M
- TRX 228.9M
- IPO Year
- CHRS 2014
- TRX N/A
- Fundamental
- Price
- CHRS $1.69
- TRX $0.81
- Analyst Decision
- CHRS Strong Buy
- TRX Strong Buy
- Analyst Count
- CHRS 4
- TRX 1
- Target Price
- CHRS $4.51
- TRX $1.10
- AVG Volume (30 Days)
- CHRS 1.4M
- TRX 3.2M
- Earning Date
- CHRS 11-05-2025
- TRX 11-28-2025
- Dividend Yield
- CHRS N/A
- TRX N/A
- EPS Growth
- CHRS N/A
- TRX N/A
- EPS
- CHRS 1.55
- TRX N/A
- Revenue
- CHRS $272,209,000.00
- TRX $47,731,000.00
- Revenue This Year
- CHRS N/A
- TRX $23.64
- Revenue Next Year
- CHRS $109.48
- TRX $51.77
- P/E Ratio
- CHRS $3.27
- TRX $775.69
- Revenue Growth
- CHRS 52.33
- TRX 29.98
- 52 Week Low
- CHRS $0.66
- TRX $0.27
- 52 Week High
- CHRS $2.43
- TRX $0.82
- Technical
- Relative Strength Index (RSI)
- CHRS 62.59
- TRX 85.17
- Support Level
- CHRS $1.63
- TRX $0.62
- Resistance Level
- CHRS $1.89
- TRX $0.81
- Average True Range (ATR)
- CHRS 0.12
- TRX 0.05
- MACD
- CHRS 0.00
- TRX 0.02
- Stochastic Oscillator
- CHRS 64.42
- TRX 99.81
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.